Equasens SA

Chart & Performance

D1W1MN

P/E

13.96

P/S

2.99

EPS

3.13

Div Yield, %

2.63%

Shrs. gr., 5y

—

Rev. gr., 5y

8.16%

Revenues

220m

+2.67%

Net income

47m

+1.45%

CFO

62m

+8.10%

Dividend

Jul 02, 20241.25 EUR/sh

Earnings

Mar 27, 2025

Profile

Equasens Société anonyme provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists' business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services. In addition, it offers a ULTIMATE, a system combining optimized pharmacy management and improved patient support; FARMACLICK, a protocol for communications between pharmacies and wholesalers-distributors; DIFARM, a solution for wholesalers-distributors; PHARE, a retail management tool; SOPHIA, a pharmacy management application; OffiMédia POS display; eNephro to enhance the care of chronic renal failure patients; and TPE Pilot, a web-based application that simplifies the management and sharing of patient education programs. Further, the company provides NOVIACARE; CARELIB Domicile; CARELIB EHPAD; KAPELSE solutions; TITAN solutions; ANTHADINE software and MOBISOINS mobile tool; MICROSOINS, an in-home nursing care solution; and LOGICLIC. Additionally, it offers AXIGATE solutions to manage the entire patient care pathway; CHORUS platform; medical telesecretarial services for healthcare professionals; and equipment lease financing solutions. The company was incorporated in 1996 and is based in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.

URL

https://pharmagest.com/

IPO date

Oct 20, 2000

Employees

1,221

Domiciled in

Incorporated in

Valuation

Order:

Title EUR in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title EUR in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12	2014‑12
Income
Revenues	219,788 2.67%	214,075 10.88%	193,069 12.41%
Cost of revenue	149,910	75,104	59,253
Unusual Expense (Income)
NOPBT	69,878	138,971	133,816
NOPBT Margin	31.79%	64.92%	69.31%
Operating Taxes	9,702	6,179	10,621
Tax Rate	13.88%	4.45%	7.94%
NOPAT	60,176	132,792	123,195
Net income	47,047 1.45%	46,376 18.55%	39,119 27.37%
Dividends	(17,289)	(15,757)	(14,269)
Dividend yield	1.86%	1.39%	1.00%
Proceeds from repurchase of equity	14	6,064	21,061
BB yield	0.00%	-0.53%	-1.48%
Debt
Debt current	22,345	18,083	17,096
Long-term debt	57,676	58,424	69,595
Deferred revenue		(48,433)	9,559
Other long-term liabilities	9,803	54,356	324
Net debt	(68,977)	(8,764)	(1,515)
Cash flow
Cash from operating activities	61,590	56,977	47,516
CAPEX	(18,417)	(10,226)	(10,422)
Cash from investing activities	(50,532)	(18,342)	(36,193)
Cash from financing activities	(16,087)	(38,272)	(9,797)
FCF	1,102	131,420	122,989
Balance
Cash	54,685	68,012	64,794
Long term investments	94,313	17,259	23,412
Excess cash	138,009	74,567	78,553
Stockholders' equity	237,652	57,188	48,384
Invested Capital	168,693	210,596	201,065
ROIC	31.73%	64.52%	63.44%
ROCE	22.67%	51.60%	53.34%
EV
Common stock shares outstanding	15,174	15,174	15,174
Price	61.10 -18.21%	74.70 -20.53%	94.00 -15.62%
Market cap	927,139 -18.21%	1,133,507 -20.53%	1,426,368 -15.03%
EV	866,511	1,131,764	1,431,579
EBITDA	83,100	152,924	145,727
EV/EBITDA	10.43	7.40	9.82
Interest	669	679	589
Interest/NOPBT	0.96%	0.49%	0.44%